Weekly Executive & Director Moves (July 28)

by | Jul 27, 2023

Boardroom Alpha provides in-depth analytics and tracking of all public company executives and officers. Below is a rundown of people moves made at notable companies this past week. Get a demo today to see how you can receive real-time alerts and in-depth analytics.

Moves in this Issue

CEO

ATER, FARO, FGEN, GPS, LECO, ORLY, POWW, PRFT, VATE, WSBF, XXII

CFO

CHWY, GRNA, PASG, PCYO, PZZA, SAM, VAC

Directors

ANGO, ARCH, ATER, BDX, BF.B, BLNK, BSM, CABA, CCI, CCLP, CIVB, CMA, CSV, CVKD, DLTH, DNB, DXC, EVH, FARO, FGEN, FRPT, FRTX, GHI, GLUE, GRNA, GT, GWW, ITRI, KLAC, KWR, LECO, LTC, LXRX, NTNX, NVDA, PMGM, POWW, PPG, PTC, PZZA, QNCX, SHAK, SIVBQ, SR, STC, STEL, URGN, VATE, VSTO, XGN, XXII

CEO Moves

22ND CENTURY GROUP INC (XXII)
Leaving: CEO – James A Mish ( 3.2 yrs; -32.9% TSR)
Replaced by: John J Miller

John J. Miller , age 58, President of Tobacco . Mr. Miller has served as our President of Tobacco since November 2022. Prior to that time, he was the President and CEO of Swisher International, Inc., a manufacturer and exporter of cigars and smokeless tobacco products in the U.S. Mr. Miller joined Swisher in November of 2012 as Senior Vice President of Sales & Marketing, was promoted to President …read full bio

AMMO INC (POWW)
Leaving: CEO – Fred W Wagenhals ( 6.6 yrs; -1.4% TSR)
Replaced by: Jared Rowe Smith

Mr. Smith, 45, has more than 17 years of experience in the ammunition industry. Prior to joining the Company in January 2023, Mr. Smith was employed at Fiocchi of America, a global manufacturer of premium ammunition for competition, hunting and defense applications located in Ozark, Missouri from 2010 to December 2022, where, since 2017, he has held the position of General Manager. As General M…read full bio

ATERIAN INC (ATER)
Leaving: CEO – Yaniv Zion Sarig ( 4.8 yrs; -47.0% TSR)
Replaced by: Joseph A Risico

Joseph A. Risico has served as our c hief l egal o fficer since March 2021 and Head of M&A since July 2021. Prior to that, he served as our g eneral c ounsel since September 2018 and has served as g eneral c ounsel for Aterian Opco since February 2018. Prior to joining Aterian, Mr. Risico held a number of legal and business positions, most recently at AutoModality, Inc., a UAV flight control softw…read full bio

ATERIAN INC (ATER)
Leaving: CEO – Yaniv Zion Sarig ( 4.8 yrs; -47.0% TSR)
Replaced by: Arturo Rodriguez

Arturo Rodriguez has served as our c hief f inancial o fficer since March 2021 and was appointed i nterim c hief o perating o fficer in May 2023. Prior to that, he served as our s enior v ice p resident of Finance since September 2017. Prior to joining the Company, Mr. Rodriguez served as c hief a ccounting o fficer and g lobal c ontroller for Piksel, Inc. from July 2012 to September 2017 and also…read full bio

FARO TECHNOLOGIES INC (FARO)
Leaving: CEO – Yuval Wasserman ( .0 yrs; )
Replaced by: Peter James Lau

Mr. Lau, who is 43, most recently served as Chief Executive Officer and a board member of Catalyst Nutraceuticals, a portfolio company of MSouth Equity Partners, from October 2022 to July 2023. From August 2020 to September 2022, Mr. Lau served as President of the Electrical segment of Hubbell Incorporated. Mr. Lau served as President of Honeywell’s global Fire Detection and Control busin…read full bio

FIBROGEN INC (FGEN)
Leaving: CEO – Enrique A Conterno ( 3.5 yrs; -55.7% TSR)
Replaced by: Thane Wettig

Mr. Wettig, who has served as the Company’s Chief Commercial Officer since June 2020, has more than 30 years of global biopharmaceutical leadership and commercial experience. Mr. Wettig previously served as Chief Commercial Officer and Metabolic Franchise Head at Intarcia Therapeutics. Prior to joining Intarcia in 2018, Mr. Wettig served as Chief Marketing Officer (Vice President of Global Marketi…read full bio

LINCOLN ELECTRIC HOLDINGS INC (LECO)
Leaving: CEO – Christopher L Mapes ( 11.0 yrs; 17.2% TSR)
Replaced by: Steven B Hedlund

Steven B. Hedlund 56 Executive Vice President, Chief Operating Officer since May 9, 2022; Executive Vice President and President, Americas and International Welding from October 21, 2020 to May 9, 2022; Executive Vice President and President, International Welding from June 1, 2017 to October 21, 2020; Senior Vice President and President, Global Automation from January 22, 2015 to June 1, 2017…read full bio

O REILLY AUTOMOTIVE INC (ORLY)
Leaving: CEO – Gregory D Johnson ( 5.7 yrs; 30.5% TSR)
Replaced by: Brad W Beckham

Mr. Beckham, age 44, has been an O’Reilly Team Member since 1996. Mr. Beckham’s O’Reilly career began as a Parts Specialist and progressed through the roles of Store Manager, District Manager, Regional Manager, Divisional Vice President, Vice President of Eastern Store Operations and Sales, Senior Vice President of Eastern Store Operations and Sales, Senior Vice President of Central Store Operatio…read full bio

PERFICIENT INC (PRFT)
Leaving: CEO – Jeffrey S Davis ( 20.8 yrs; 26.0% TSR)
Replaced by: Thomas J Hogan

Thomas J. Hogan was appointed as the Company’s President in February 2021 and began serving as our COO in 2018. Mr. Hogan joined the Company in January 2008 and has served the Company in several capacities, including Vice President of Field Operations, General Manager, Director of Business Development, and 

CFO Moves

BOSTON BEER CO INC (SAM)
Leaving: CFO – Matthew Donal Murphy ( .5 yrs; )
Replaced by: Diego Reynoso

Diego Reynoso, age 47, Mr. Reynoso has over 25 years of experience in finance and operations in the alcoholic beverage and food industry. Most recently, he served as the Chief Financial Officer of the Prepared Foods division of Tyson Foods, a multinational food manufacturer, based out of its Chicago office, from 2021 to 2023. From 2017 to 2021, he served as Senior Vice President and Chief Finan…read full bio

CHEWY INC (CHWY)
Leaving: CFO – Mario Jesus Marte ( 4.8 yrs; 2.2% TSR)
Replaced by: Stacy Bowman

Ms. Bowman, age 44, is currently the Company’s Chief Accounting Officer, a position she has held since April 2023. From March 2018 to April 2023, Ms. Bowman served as the Company’s Vice President, Principal Accounting Officer and from April 2015 to March 2018, she served as the Company’s Corporate Controller. 

read full bio

GREENLIGHT BIOSCIENCES HOLDINGS PBC (GRNA)
Leaving: CFO – Susan Keefe ( 1.4 yrs; -90.3% TSR)
Replaced by: Clay Mitchell

Clay Mitchell is a member of Fall Line GP. Mr. Mitchell is also a co-founder and a Managing Director at Fall Line Capital, LLC (“Fall Line Capital”), a private equity firm focused on investments in farmland and agricultural. technologies. Mr. Mitchell, together with Mr. O’Brien (as described below) founded Fall Line Capital in 2011 and has worked at Fall Line Capital since 201…read full bio

MARRIOTT VACATIONS WORLDWIDE CORP (VAC)
Leaving: CFO – Anthony Terry ( 1.9 yrs; -8.5% TSR)
Replaced by: Jason P. Marino

Mr. Marino, 47, has served as Senior Vice President, Strategy, FP&A and Operational Finance – Vacation Ownership for the Company since December 2021. He served as the Company’s Senior Vice President of Strategy and FP&A from June 2019 to December 2021 and Vice President – Corporate Finance from May 2014 to June 2019. Prior to joining the Company in 2014, Mr. Marino worked at Can…read full bio

PAPA JOHNS INTERNATIONAL INC (PZZA)
Leaving: CFO – Christopher L Collins ( .3 yrs; )
Replaced by: Ravi Thanawala

Mr. Thanawala, 39, served as the Vice President and CFO of Nike North America since 2020, where he provided enterprise market strategy and financial management for Nike, Inc.’s largest division.  During his seven years with Nike, Inc., he also served as the Global Vice President and CFO of Converse (2018– 2020) as well as the Global Vice President, Retail Excellence (2016&ndash…read full bio

PASSAGE BIO INC (PASG)
Leaving: CFO – Simona King ( 1.9 yrs; -73.2% TSR)
Replaced by: Kathleen Borthwick

Ms. Borthwick, age 47, will serve as our Senior Vice President and Interim Chief Financial Officer effective July 28, 2023. From November 2021 to July 2023, Ms. Borthwick served as our Vice President of Finance. From June 1997 to October 2021, Ms. Borthwick served in various leadership roles of increasing responsibility at Johnson & Johnson….read full bio

Director Joins

AMMO INC (POWW)
Jared Rowe Smith

Mr. Smith, 45, has more than 17 years of experience in the ammunition industry. Prior to joining the Company in January 2023, Mr. Smith was employed at Fiocchi of America, a global manufacturer of premium ammunition for competition, hunting and defense applications located in Ozark, Missouri from…read full bio
ANGIODYNAMICS INC (ANGO)
Lorinda Burgess

Ms. Burgess brings over 35 years of management, financial, and global operations experience, including over 15 years at Medtronic, Inc., where she was responsible for the company’s Americas Region as CFO, Vice President of Finance. While at Medtronic, Ms. Burgess led optimization initiative…read full bio
ATERIAN INC (ATER)
Arturo Rodriguez

Arturo Rodriguez has served as our c hief f inancial o fficer since March 2021 and was appointed i nterim c hief o perating o fficer in May 2023. Prior to that, he served as our s enior v ice p resident of Finance since September 2017. Prior to joining the Company, Mr. Rodriguez served as c hief a c…read full bio
ATERIAN INC (ATER)
Joseph A Risico

Joseph A. Risico has served as our c hief l egal o fficer since March 2021 and Head of M&A since July 2021. Prior to that, he served as our g eneral c ounsel since September 2018 and has served as g eneral c ounsel for Aterian Opco since February 2018. Prior to joining Aterian, Mr. Risico held a num…read full bio
CABALETTA BIO INC (CABA)
Shawn Tomasello

Ms. Tomasello has over 35 years of experience in the life sciences industry, including specific expertise in CD19-CAR T therapy, where she most recently served as the Chief Commercial Officer of Kite Pharma, Inc. between 2015 and 2018, leading the worldwide commerciali…read full bio


CADRENAL THERAPEUTICS INC (CVKD)
Robert Lisicki

Mr. Lisicki, age 56, currently serves as an independent consultant and advisor to both public and private pharmaceutical and biotechnology companies. From October 2022 until March 2023, he served as the Chief Executive Officer and board member of InCarda Therapeutics, Inc., a privately held clini…read full bio
CARRIAGE SERVICES INC (CSV)
Julie Sanders

Ms. Sanders has over 30 years of financial and audit leadership experience, along with extensive experience in transformative initiatives as it relate to financial systems, including the development and implementation of large-scale enhancements and capabilities. Ms. Sanders currently serves as S…read full bio
CIVISTA BANCSHARES INC (CIVB)
Gerald B Wurm

Gerald B. Wurm is President of Wurm’s Woodworking Co., located in New Washington, Ohio, which is engaged in the fabrication of wood, polymer and vacuum formed plastic products for various industries, and also President of Creative Plastics International, Inc., located in Jackson Center, Ohio, which …read full bio


COMERICA INC (CMA)
Arthur G. Angulo

Angulo, who has served in his role as Managing Director of Promontory Financial Group since 2014, counsels clients on a variety of risk management and regulatory compliance matters. Angulo also has deep risk and regulatory expertise from his career at the Federal Reserve Bank of read full bioDUN & BRADSTREET HOLDINGS INC (DNB)
Kirsten Marie Kliphouse

Ms. Kliphouse’s term as a member of our Board of Directors will expire at the annual meeting of our shareholders to be held in 2024. Ms. Kliphouse has not been appointed to any committee of our Board. Ms. Kliphouse, who is 57, served as President of Google Cloud Americas, where she was responsible f…read full bio
FARO TECHNOLOGIES INC (FARO)
Peter James Lau

Mr. Lau, who is 43, most recently served as Chief Executive Officer and a board member of Catalyst Nutraceuticals, a portfolio company of MSouth Equity Partners, from October 2022 to July 2023. From August 2020 to September 2022, Mr. Lau served as President of the Electrical segment of Hubbell In…read full bioGREENLIGHT BIOSCIENCES HOLDINGS PBC (GRNA)
Clay Mitchell

Clay Mitchell is a member of Fall Line GP. Mr. Mitchell is also a co-founder and a Managing Director at Fall Line Capital, LLC (“Fall Line Capital”), a private equity firm focused on investments in farmland and agricultural. technologies. Mr. Mitchell, together with Mr. O’Brien …read full bio
GREYSTONE HOUSING IMPACT INVESTORS LP (GHI)
Robert K. Jacobsen

Robert K. Jacobsen, 67, has over 40 years of professional experience including serving as a Managing Director at Merrill Lynch, Goldman Sachs, and Fundamental Advisors. In that time, he has accumulated expertise in the underwriting, trading, and sale of municipal bonds with a particular focus on …read full bioKLA CORP (KLAC)
Michael R McMullen

Mr. McMullen has served as the President, since 2014, and Chief Executive Officer, since 2015, of Agilent Technologies, Inc. (“Agilent”), a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, …read full bio


LINCOLN ELECTRIC HOLDINGS INC (LECO)
Bonnie J Fetch

Ms. Fetch serves as Vice President, Global Supply Chain and Manufacturing, for Cummins Inc., a global power technology solutions leader. In this role, she leads Cummins’ complex and integrated global supply chain functions, as well as Cummins’ New and ReCon Parts business and Rem…read full bio
LTC PROPERTIES INC (LTC)
David L Gruber

Gruber, 53, is a qualified financial expert with significant corporate finance, governance and compliance expertise, having served as Managing Director, Head of Equity Capital Markets for KeyBanc Capital Markets for more than 20 years, where he chaired and was a member of the bank’s Equity …read full bio


MONTE ROSA THERAPEUTICS INC (GLUE)
Anthony M Manning

Dr. Manning serves as a Board Director for Palatin Technologies, Founder and Chair of the non-profit Institute for Biomedical Entrepreneurship, and Scientific Advisor for several companies. Most recently, Dr. Manning was Chief Scientific Officer at Momenta Pharmaceuticals, where he built a pipeline …read full bio
NUTANIX INC (NTNX)
Mark B Templeton

Templeton was most recently CEO of DigitalOcean, and prior to that spent 20 years at Citrix Systems (a Nutanix Partner), including 14 years as President and CEO. He has served on the board of directors of multiple NYSE and NASDAQ companies. Templeton currently serves on the boards of Arista Netwo…read full bio


PRIVETERRA ACQUISITION CORP (PMGM)
Shelley B Thunen

Shelley Thunen, 70 Since February 2017, Ms. Thunen has served as the Chief Financial Officer of RxSight, Inc. (NASDAQ: RXST) where she began in January 2016 as its Chief Administrative Officer. From January 2013 to October 2015, Ms. Thunen served a…read full bio
PRIVETERRA ACQUISITION CORP (PMGM)
Marc Forth

Marc Forth, 52, Mr. Forth has served as the Chief Executive Officer of AEON since December 2019 and as Chief Executive Officer of ABP Sub Inc., AEON’s wholly owned subsidiary, since May 2019. Prior to that time, Mr. Forth was the Senior Vice President of Allergan PLC and…read full bio


PRIVETERRA ACQUISITION CORP (PMGM)
Eric G Carter

Dr. Eric Carter, 71, Since April 2021 Dr. Carter has served as CMO for IACTA Pharmaceuticals and in January 2022 he became a member of the board of directors of Visgenx, where he also serves as the chair of the scientific advisory committee. From…read full bio


PRIVETERRA ACQUISITION CORP (PMGM)
Jost Fischer

Jost Fischer, 69, has served as a member of our board of directors since February 2017 and serves on our board of directors as a representative of Dental Innovations BVBA. Mr. Fischer is the co-owner of Dental Innovations BVBA. Mr. Fischer served as a member and …read full bio


SHAKE SHACK INC (SHAK)
Charles J Chapman III

Mr. Chapman was appointed as a Class III member who will stand for election at the 2024 Annual Meeting. T he Board has determined that Mr. Chapman is independent under the listing standards of the New York Stock Exchange and the Company’s Corporate Governance Guidelines. Mr. Chapman has been appoint…read full bio
SPIRE INC (SR)
Paul D Koonce

Mr. Koonce retired from Dominion Energy Inc. (“Dominion”) in February 2020 after a 38-year career in the energy sector, where he most recently served as executive vice president of Dominion and president and CEO of Dominion’s Power Generation Group. Mr. Koonce was elected to join the class of direct…read full bio
STELLAR BANCORP INC (STEL)
Cynthia Dopjera

Ms. Dopjera currently serves as a member of the Board of Directors of the Company’s wholly owned subsidiary, Stellar Bank, where she also serves as the Chair of the Audit Committee. Ms. Dopjera served as a member of the Board of Directors of Allegiance Bank beginning in 2019 prior to its merger with…read full bio

 

Director Exits

ATERIAN INC (ATER)
Yaniv Zion Sarig ( 4.1 yrs; -47.0% TSR)


BLINK CHARGING CO (BLNK)
Kenneth R Marks ( 3.3 yrs; 30.7% TSR)
Committees: Audit, Compensation, Environmental, Social and Governance

BLINK CHARGING CO (BLNK)
Michael D Farkas ( 13.3 yrs; -36.3% TSR)


BLINK CHARGING CO (BLNK)
Louis R Buffalino ( 3.6 yrs; 38.7% TSR)
Committees: Audit, Compensation, Environmental, Social and Governance, Nominating (and Governance)

BROWN FORMAN CORP (BF.B)
John D Cook ( 14.8 yrs; 12.5% TSR)
Committees: Compensation, Executive, Nominating (and Governance)

CARRIAGE SERVICES INC (CSV)
Barry K Fingerhut ( 11.3 yrs; 17.4% TSR)
Committees: Audit, Compensation, Nominating (and Governance)

DXC TECHNOLOGY CO (DXC)
Amy E Alving ( 6.3 yrs; -12.2% TSR)
Committees: Audit, Nominating (and Governance), Risk

DXC TECHNOLOGY CO (DXC)
Mukesh Aghi ( 6.3 yrs; -12.2% TSR)
Committees: Compensation

FIBROGEN INC (FGEN)
Enrique A Conterno ( 3.5 yrs; -55.7% TSR)


FRESHPET INC (FRPT)
Charles A Norris ( 16.8 yrs; 16.1% TSR)


FRESH TRACKS THERAPEUTICS INC (FRTX)
Robert Busard Brown ( 3.9 yrs; -76.4% TSR)


GREENLIGHT BIOSCIENCES HOLDINGS PBC (GRNA)
Matthew Alan Walker ( 1.4 yrs; -90.3% TSR)


GREENLIGHT BIOSCIENCES HOLDINGS PBC (GRNA)
Charles L Cooney ( 1.4 yrs; -90.3% TSR)


GREENLIGHT BIOSCIENCES HOLDINGS PBC (GRNA)
Ganesh Kishore ( 1.4 yrs; -90.3% TSR)


GREENLIGHT BIOSCIENCES HOLDINGS PBC (GRNA)
Jennifer E Pardi ( 2.6 yrs; -76.2% TSR)


GREENLIGHT BIOSCIENCES HOLDINGS PBC (GRNA)
Juan Andrey Zarur ( 1.4 yrs; -90.3% TSR)


GREENLIGHT BIOSCIENCES HOLDINGS PBC (GRNA)
Eric Obrien ( 1.4 yrs; -90.3% TSR)


GREENLIGHT BIOSCIENCES HOLDINGS PBC (GRNA)
Martha Schlicher ( 1.4 yrs; -90.3% TSR)


INNOVATE CORP (VATE)
Wayne Barr Jr ( 9.5 yrs; -4.4% TSR)
Committees: Audit, Compensation, Executive, Nominating (and Governance)

LEXICON PHARMACEUTICALS INC (LXRX)
Frank Palantoni ( 27.8 yrs; -14.6% TSR)
Committees: Audit, Compensation

VISTA OUTDOOR INC (VSTO)
Frances P Philip ( 3.1 yrs; 46.7% TSR)
Committees: Audit, Management Development and Compensation, Nominating (and Governance)


Recent Analysis

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.